Cholesterol metabolism: a positive target to revoke the function of exhausted CAR-NK cells in tumor microenvironment
Author:
Open Access
- 16 September 2024
- journal article
- editorial
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 15, 1440869
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapyJournal of Experimental & Clinical Cancer Research, 2022
- CRISPR screens identify cholesterol biosynthesis as a therapeutic target on stemness and drug resistance of colon cancerOncogene, 2021
- Increased lipid metabolism impairs NK cell function and mediates adaptation to the lymphoma environmentBlood, 2020
- Cholesterol metabolism in cancer: mechanisms and therapeutic opportunitiesNature Metabolism, 2020
- Myeloid immunosuppression and immune checkpoints in the tumor microenvironmentCellular & Molecular Immunology, 2019
- NK Cell Metabolism and Tumor MicroenvironmentFrontiers in Immunology, 2019
- Cholesterol Induces CD8+ T Cell Exhaustion in the Tumor MicroenvironmentCell Metabolism, 2019
- Downregulation of SREBP inhibits tumor growth and initiation by altering cellular metabolism in colon cancerCell Death & Disease, 2018
- Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic LeukemiaNew England Journal of Medicine, 2018
- Identification of a tumor-promoter cholesterol metabolite in human breast cancers acting through the glucocorticoid receptorProceedings of the National Academy of Sciences, 2017